Schisandrin B inhibits Th1/Th17 differentiation and promotes regulatory T cell expansion in mouse lymphocytes

• Schisandrin B (Sch-B) altered cytokine secretion in Con A-treated mouse splenocytes.
• Sch-B suppressed Th1/Th17 induction and T-bet/RORγt expression in mouse naïve Th cells.
• Sch-B promoted Treg induction and FoxP3 expression in mouse naïve Th cells.
• Sch-B inhibited IL-6/STAT3 pathway in mouse naïve Th cells.
• The effect of Sch-B on Th subset differentiation was eliminated by HO-1 inhibitor.

Schisandrin B (Sch-B), the most abundant active ingredient of the fruit of Schisandra chinensis, has been proposed to have antioxidant, anti-tumor and anti-inflammatory effects. The present study was undertaken to investigate the effect of Sch-B on differentiation of T helper cells (Th). Using mouse splenic lymphocytes stimulated with concanavalin A (Con A) in vitro and ex vivo as inflammation models, we found that Sch-B significantly inhibited secretion of Th1 and Th17 related cytokines, such as IFN-γ and IL-17. In addition, we found that Sch-B suppressed the differentiation of naive CD4 + T cells into Th1 and Th17 cells, while promoted their differentiation into the regulatory T cells (Treg) in vitro. We further found that Sch-B suppressed transcription of Th1-related T-box transcription factor, T-bet, and Th17-related transcription factor, retinoid related orphan receptor gamma t (RORγt), while enhanced transcription of Treg-related transcription factor forkhead box protein 3 (Foxp3) in naive CD4 + T cells under Th cell polarization conditions. Furthermore, the effect of Sch-B on the T cell differentiation was abrogated by heme oxygenase-1 (HO-1) inhibitor zinc protoporphyrin. Taken together, we conclude that Sch-B can modulate differentiation of naïve CD4 + T cells into specific lineages of effector cells, which may have potential benefits for treatment of autoimmune diseases.